NeoGenomics, Inc. NEO recently announced the availability of its new pan-solid tumor assay, PanTracer Pro, designed to help clinicians navigate increasingly complex molecular testing workflows to make ...

A newly available comprehensive genomic profiling (CGP) kit could expand personalized cancer research access to private laboratories worldwide, according to Roche, which developed the kit in ...

Natera's integration into OncoEMR enhances workflow efficiency, simplifying the ordering process for precision medicine tests in oncology practices. The integration supports timely treatment decisions ...

FORT MYERS, Fla.--(BUSINESS WIRE)-- NeoGenomics, Inc. (NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, will present new data demonstrating how comprehensive ...

Deep learning–based cfDNA fragment–level analysis: A genome-scanning approach for detection of colorectal cancer. This is an ASCO Meeting Abstract from the 2026 ASCO Gastrointestinal Cancers Symposium ...